Urological Cancer Services Ltd

Urological Cancer Services Ltd
Contents Page
For the year ended 28 February 2026

Accountants' Report	1
Statement of Financial Position	2
Notes to the Financial Statements	3

Urological Cancer Services Ltd Accountants' Report For the year ended 28 February 2026
Chartered Accountant's report to the board of directors on the preparation of the unaudited statutory financial statements of Urological Cancer Services Ltd for the year ended 28 February 2026. In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Urological Cancer Services Ltd for the year ended 28 February 2026 which comprise the Statement of Comprehensive Income, the Statement of Financial Position, the Statement of Changes in Equity, the Statement of Cash Flows and related notes from the companys accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at http://icaew.com/regulations. This report is made solely to the Board of Directors of Urological Cancer Services Ltd, as a body, in accordance with the terms of our engagement letter dated 11th February 2016. Our work has been undertaken solely to prepare for your approval the financial statements of Urological Cancer Services Ltd and state those matters that we have agreed to state to the Board of Directors of Urological Cancer Services Ltd, as a body, in this report in accordance with AAF 2/10 as detailed at http://icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Urological Cancer Services Ltd and its Board of Directors as a body, for our work or for this report. It is your duty to ensure that Urological Cancer Services Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Urological Cancer Services Ltd. You consider that Urological Cancer Services Ltd is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of Urological Cancer Services Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements. .................................................... KWSR & CO LTD 136 Merton High Street London SW19 1BA 09 October 2026 1

Urological Cancer Services Ltd
Accountants' Report
For the year ended 28 February 2026

Chartered Accountant's report to the board of directors on the preparation of the unaudited statutory financial statements of Urological Cancer Services Ltd for the year ended 28 February 2026.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Urological Cancer Services Ltd for the year ended 28 February 2026 which comprise the Statement of Comprehensive Income, the Statement of Financial Position, the Statement of Changes in Equity, the Statement of Cash Flows and related notes from the companys accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at http://icaew.com/regulations.

This report is made solely to the Board of Directors of Urological Cancer Services Ltd, as a body, in accordance with the terms of our engagement letter dated 11th February 2016. Our work has been undertaken solely to prepare for your approval the financial statements of Urological Cancer Services Ltd and state those matters that we have agreed to state to the Board of Directors of Urological Cancer Services Ltd, as a body, in this report in accordance with AAF 2/10 as detailed at http://icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Urological Cancer Services Ltd and its Board of Directors as a body, for our work or for this report.

It is your duty to ensure that Urological Cancer Services Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Urological Cancer Services Ltd. You consider that Urological Cancer Services Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Urological Cancer Services Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

....................................................

KWSR & CO LTD
136 Merton High Street
London
SW19 1BA
09 October 2026

1

Urological Cancer Services Ltd
Statement of Financial Position
As at 28 February 2026

	Notes	2026 £	2025 £
Fixed assets
Tangible fixed assets	3	3,972	2,314
		3,972	2,314
Current assets
Cash at bank and in hand		164,634	128,975
Creditors: amount falling due within one year		(23,295)	(27,664)
Net current assets		141,339	101,311

Total assets less current liabilities		145,311	103,625
Net assets		145,311	103,625

Capital and reserves
Called up share capital	4	100	100
Profit and loss account		145,211	103,525
Shareholders' funds		145,311	103,625

For the year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the director on 09 October 2026 and were signed by:

-------------------------------
Alan Thompson
Director

2

Urological Cancer Services Ltd
Notes to the Abridged Financial Statements
For the year ended 28 February 2026

General Information

Urological Cancer Services Ltd is a private company, limited by shares, registered in England and Wales, registration number 09992952, registration address 12 Copsem Drive, Esher, Surrey, KT10 9HD.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Website cost

Planning and operating costs for the company's website are charged to the income statement as incurred.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

Dividends

Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Fixtures and Fittings	15% Reducing Balance
Computer Equipment	15% Reducing Balance

2.	Average number of employees Average number of employees during the year was 0 (2025 : 0).

3.

Tangible fixed assets

Cost or valuation	Fixtures and Fittings	Computer Equipment	Total
	£	£	£
At 01 March 2025	2,978	1,799	4,777
Additions	-	2,230	2,230
Disposals	-	-	-
At 28 February 2026	2,978	4,029	7,007
Depreciation
At 01 March 2025	1,203	1,260	2,463
Charge for year	267	305	572
On disposals	-	-	-
At 28 February 2026	1,470	1,565	3,035
Net book values
Closing balance as at 28 February 2026	1,508	2,464	3,972
Opening balance as at 01 March 2025	1,775	539	2,314

4.

Share Capital

Allotted, called up and fully paid	2026 £		2025 £
100 Ordinary shares of £1.00 each	100		100
	100		100

3